Free webinar: Update on EMA and FDA’s approach to tackling drug shortages

Published: 3-Sep-2020 Featured companies: NSF
Regulatory Pharmaceutical

The webinar will be hosted on 8 September, 2020 – 1pm BST

Presented by NSF expert John Johnson, find out how the EMA and FDA are working with industry to tackle drug shortages and how this might impact the scope of your next regulatory inspection. He will also discuss the key causes of drug shortages, including their effect on global healthcare.

Register now: https://go.pardot.com/l/129231/2020-08-10/39yrb7

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

NSF International launches two water fitting accreditations

Read more
New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. The colouration of tablets and capsules Paul Smith from Sensient Pharmaceutical Technologies discusses the use of colour in solid oral dosage forms
  3. Optimising the blending of flow aids in powder formulations Flow aids are used routinely in pharmaceutical manufacturing to enhance the process performance of powder blends and safeguard the critical quality attributes of finished products
  4. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

NSF International launches two water fitting accreditations

New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market
Regulatory

2022 Pharma Training Courses from NSF

Start your year right and keep your goals on track with NSF’s training and education. NSF's pharma training and education programs focus on changing behaviours at both an individual and organisation-wide level
Regulatory

NSF explains why you might need a remediation program

The team at NSF explores why remediation projects are needed, the traits of successful programs and what to do to ensure success in your remediation efforts
Finance

Remediating pharmaceutical quality systems

Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your remediation project a success
Regulatory

Pharmaceutical legislation update subscription service

Sign up for NSF’s September start date
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

White paper: Streamlining Pharma Operations in the Wake of COVID-19

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris
Subscribe now